Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Feasibility of identifying POLE-mutated endometrial carcinoma through a pathological features-based scoring system].

Zhonghua bing li xue za zhi = Chinese journal of pathology - 8 Apr 2026

Hu A J, Liu Y, Wang Y X, Yang J, Song Z X, Zhao X Y, Liu L C, Liu C R

Abstract excerpt

Objective: To assess the utility of histopathological and immunohistochemical characteristics in identifying POLE-mutated (POLEmut) endometrial carcinoma (EC). Methods: A total of 1 541 EC cases that underwent molecular classification at Peking University Third Hospital from January 2018 to December 2024 were included. Cases were categorized into POLEmut and non-POLEmut groups (including p53-abnormal, mismatch...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Polymerase II

Share to Endometrial Neoplasms

Share to Lymphocytes, Tumor-Infiltrating

Share to Mutation

Share to Poly-ADP-Ribose Binding Proteins

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 41956747
DOI: 10.3760/cma.j.cn112151-20250820-00564

Genes

POLE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Feasibility of identifying POLE-mutated endometrial carcinoma through a pathological features-based scoring system].PMID 41956747Read ↗

Cytopathological features associated with POLE mutation in endometrial cancer.Semantic proximity Read ↗

The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive ReviewSemantic proximity Read ↗

Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma.Semantic proximity Read ↗

Morules and β-catenin predict POLE mutation status in endometrial cancer: A pathway to more cost-effective diagnostic procedures.Semantic proximity Read ↗

The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.Semantic proximity Read ↗

POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting.Semantic proximity Read ↗

Interpretation strategy of POLE, mismatch repair deficiency, and p53 in the multiple molecular classification of endometrial carcinoma and its clinical differences from single classification: a retrospective cohort study.Semantic proximity Read ↗

[Clinicopathological and molecular genetic features of POLE-mutated endometrioid carcinoma].Semantic proximity Read ↗

The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients.Semantic proximity Read ↗

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study.Semantic proximity Read ↗

Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated Genome.Semantic proximity Read ↗

Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.